Table 2 Seroprevalence of hepatitis B and C infections among the study subjects
Variables | Status | Total (%) |
|---|---|---|
HBsAg | Positive | 17 (4.4) |
Negative | 367 (95.6) | |
Anti –HCV antibody | Positive | 1 (0.26) |
Negative | 383 (99.74) | |
Co-infection (HBsAg & HCV) | Positive | 0 (0) |
Negative | 384 (100) | |
Total | Â | 384 (100) |